Basic Information

Professional Memberships

• 日本臨床薬理学会
• 日本がん分子標的治療学会
• 日本血液学会

Academic Degree

• 博士（医学）(神戸大学)

Research History

• From Feb. 2020, To Mar. 2021

  MSD K.K, Oncology Science Unit, Oncology Scientific Affairs, Director
• From Jan. 2017, To Jan. 2020

  MSD K.K, Oncology Science Unit, Oncology Science Affairs, Associate Director
• From Apr. 2014, To Dec. 2016

  日本医療研究開発機構（AMED), がん研究課 リサーチレジデント
• From Apr. 2014, To Dec. 2016

  がん感染症センター都立駒込病院, 腫瘍内科 非常勤医員
• From Apr. 2012, To Mar. 2014

  National Cancer Center, 計画治療病棟支援施設 リサーチレジデント
• From Apr. 2009, To Mar. 2012

  がん感染症センター都立駒込病院, 腫瘍内科専攻後期研修医
• From Apr. 2007, To Mar. 2009

  がん感染症センター都立駒込病院, 内科系初期研修医

ID,URL

• J-Global ID

  201401026630114907

researchmap URL

• https://researchmap.jp/tsawada

Research

Research Areas

• Life sciences, Tumor diagnostics and therapeutics

Papers

• Abstract 1334: Chemotherapy regulated microRNA-125/HER2 pathway as a novel therapeutic target for trastuzumab-mediated cellular cytotoxicity in small-cell lung cancer

  Shigehiro Yagishita; Yu Fujita; Yuichi Fujimoto; Fumiyuki Takahashi; Kazuhisa Takahashi; Tomohide Tamura; Fumiaki Koizumi

  Cancer Research, 01 Aug. 2015

  
• 403 A novel dielectrophoretic microwell array system for detection and single cell analysis of circulating tumor cells from breast cancer patients

  T. Sawada; A. Morimoto; T. Mogami; K. Iijima; Y. Akiyama; K. Katayama; T. Futami; M. Yunokawa; K. Tamura; M. Watanabe; Y. Koh; F. Koizumi

  European Journal of Cancer, Nov. 2014

  
• Delayed CD4 +T-cell response in older adults is associated with reduced immunogenicity and reactogenicity after COVID-19 mRNA vaccination

  Norihide Jo; Yu Hidaka; Osamu Kikuchi; Masaru Fukahori; Takeshi Sawada; Masahiko Aoki; Masaki Yamamoto; Miki Nagao; Satoshi Morita; Takako E Nakajima; Manabu Muto; Yoko Hamazaki

  The Journal of Immunology, 01 May 2023

  
• Abstract 907: Evaluation of the anti-GPC1 scFv-Fc fusion protein as a detection tool of GPC1 expression in human cancers

  Takeshi Sawada; Tomonori Yaguchi; Yuko Sakai; Chinatsu Suzuki; Kenji Morii; Masahiko Aoki; Masaru Fukahori; Satoshi Serada; Tetsuji Naka; Jun K. Yamashita; Yutaka Kawakami; Takako E. Nakajima

  Cancer Research, 04 Apr. 2023

  
• Author Correction: Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination

  Norihide Jo; Yu Hidaka; Osamu Kikuchi; Masaru Fukahori; Takeshi Sawada; Masahiko Aoki; Masaki Yamamoto; Miki Nagao; Satoshi Morita; Takako E. Nakajima; Manabu Muto; Yoko Hamazaki

  Nature Aging, 02 May 2023

  
• Primary results from Japanese phase I study of pembrolizumab plus chemotherapy as front-line therapy for advanced NSCLC

  Takayasu Kurata; Kazuhiko Nakagawa; Miyako Satouchi; Takashi Seto; Takeshi Sawada; Shi Rong Han; Kazuo Noguchi; Takashi Shimamoto; Naoyuki Nogami

  Annals of Oncology, Oct. 2019

  
• Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042

  K. Nosaki; Y. Hosomi; H. Saka; P. Baas; G. de Castro; M. Reck; Y.-L. Wu; J.R. Brahmer; E. Felip; T. Sawada; K. Noguchi; S.R. Han; B. Piperdi; D.A. Kush; G. Lopes

  Annals of Oncology, Apr. 2019

  
• Transcriptomic profiling of single circulating tumor cells provides insight into human metastatic gastric cancer.

  Ryo Negishi; Hitomi Yamakawa; Takeru Kobayashi; Mayuko Horikawa; Tatsu Shimoyama; Fumiaki Koizumi; Takeshi Sawada; Keisuke Oboki; Yasushi Omuro; Chikako Funasaka; Akihiko Kageyama; Yusuke Kanemasa; Tsuyoshi Tanaka; Tadashi Matsunaga; Tomoko Yoshino

  Communications biology, 11 Jan. 2022

  
• Phase 1 study of pembrolizumab plus chemotherapy as first-line treatment in Japanese patients with advanced NSCLC

  Takayasu Kurata; Kazuhiko Nakagawa; Miyako Satouchi; Takashi Seto; Takeshi Sawada; Shirong Han; Masae Homma; Kazuo Noguchi; Naoyuki Nogami

  Cancer Treatment and Research Communications, 2021

  
• Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies.

  Kaname Nosaki; Hideo Saka; Yukio Hosomi; Paul Baas; Gilberto de Castro Jr; Martin Reck; Yi-Long Wu; Julie R Brahmer; Enriqueta Felip; Takeshi Sawada; Kazuo Noguchi; Shi Rong Han; Bilal Piperdi; Debra A Kush; Gilberto Lopes

  Lung cancer (Amsterdam, Netherlands), Sep. 2019, Peer-reviewed

  
• Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profiles.

  Takeshi Sawada; Riet Hilhorst; Savithri Rangarajan; Masayuki Yoshida; Yuko Tanabe; Kenji Tamura; Takayuki Kinoshita; Tatsu Shimoyama; Rinie van Beuningen; Rob Ruijtenbeek; Hitoshi Tsuda; Fumiaki Koizumi

  Oncotarget, 28 Sep. 2018

  
• Correction: Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients.

  Shun-Ichiro Kageyama; Keiji Nihei; Katsuyuki Karasawa; Takeshi Sawada; Fumiaki Koizumi; Shigeo Yamaguchi; Shunsuke Kato; Hidehiro Hojo; Atsushi Motegi; Katsuya Tsuchihara; Tetsuo Akimoto

  Oncotarget, 04 May 2018

  
• Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients.

  Shun-Ichiro Kageyama; Keiji Nihei; Katsuyuki Karasawa; Takeshi Sawada; Fumiaki Koizumi; Shigeo Yamaguchi; Shunsuke Kato; Hidehiro Hojo; Atsuhi Motegi; Katsuya Tsuchihara; Tetsuo Akimoto

  Oncotarget, 10 Apr. 2018

  
• Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients.

  Yusuke Kanemasa; Tatsu Shimoyama; Yuki Sasaki; Miho Tamura; Takeshi Sawada; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda

  Hematological oncology, Feb. 2018, Peer-reviewed

  
• Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma.

  Yusuke Kanemasa; Tatsu Shimoyama; Yuki Sasaki; Miho Tamura; Takeshi Sawada; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda

  Hematological oncology, Dec. 2017, Peer-reviewed

  
• The impacts of initial and relative dose intensity of R-CHOP on outcomes of elderly patients with diffuse large B-cell lymphoma.

  Yusuke Kanemasa; Tatsu Shimoyama; Yuki Sasaki; Miho Tamura; Takeshi Sawada; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda

  Leukemia & lymphoma, Mar. 2017, Peer-reviewed

  
• Analysis of prognostic value of complete response by PET-CT and further stratification by clinical and biological markers in DLBCL patients.

  Yusuke Kanemasa; Tatsu Shimoyama; Yuki Sasaki; Miho Tamura; Takeshi Sawada; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda

  Medical oncology (Northwood, London, England), Feb. 2017, Peer-reviewed

  
• A convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma.

  Yusuke Kanemasa; Tatsu Shimoyama; Yuki Sasaki; Takeshi Sawada; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda

  Leukemia & lymphoma, Oct. 2016, Peer-reviewed

  
• Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model.

  Yusuke Kanemasa; Tatsu Shimoyama; Yuki Sasaki; Miho Tamura; Takeshi Sawada; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda

  Annals of hematology, Oct. 2016, Peer-reviewed

  
• Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer.

  Takeshi Sawada; Jungo Araki; Toshinari Yamashita; Manami Masubuchi; Tsuneko Chiyoda; Mayu Yunokawa; Kumiko Hoshi; Shoichi Tao; Shohei Yamamura; Shouki Yatsushiro; Kaori Abe; Masatoshi Kataoka; Tatsu Shimoyama; Yoshiharu Maeda; Katsumasa Kuroi; Kenji Tamura; Tsuneo Sawazumi; Hironobu Minami; Yoshihiko Suda; Fumiaki Koizumi

  EBioMedicine, Sep. 2016, Peer-reviewed

  
• Prognostic impact of CTC detected using a novel fluidic cell microarray chip CTC detection system in patients with breast cancer

  Takeshi Sawada; Jungo Araki; Toshinari Yamashita; Manami Masubuchi; Tsuneko Chiyoda; Mayu Yunokawa; Kumiko Hoshi; Shoichi Tao; Shohei Yamamura; Shouki Yatsushiro; Kaori Abe; Masatoshi Kataoka; Tatsu Shimoyama; Yoshiharu Maeda; Katsumasa Kuroi; Kenji Tamura; Tsuneo Sawazumi; Hironobu Minami; Yoshihiko Suda; Fumiaki Koizumi

  CANCER RESEARCH, Jul. 2016, Peer-reviewed

  
• Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells.

  Takeshi Sawada; Masaru Watanabe; Yuu Fujimura; Shigehiro Yagishita; Tatsu Shimoyama; Yoshiharu Maeda; Shintaro Kanda; Mayu Yunokawa; Kenji Tamura; Tomohide Tamura; Hironobu Minami; Yasuhiro Koh; Fumiaki Koizumi

  Cancer science, Mar. 2016, Peer-reviewed

  
• Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1.

  Yoshiro Nakahara; Yusuke Takagi; Yukio Hosomi; Akiko Kagei; Tomohiro Yamamoto; Takeshi Sawada; Makiko Yomota; Yusuke Okuma; Shinichiro Mikura; Tatsuru Okamura

  OncoTargets and therapy, 2016, Peer-reviewed

  
• Chemotherapy-Regulated microRNA-125-HER2 Pathway as a Novel Therapeutic Target for Trastuzumab-Mediated Cellular Cytotoxicity in Small Cell Lung Cancer.

  Shigehiro Yagishita; Yu Fujita; Satoru Kitazono; Ryo Ko; Yusuke Nakadate; Takeshi Sawada; Yuka Kitamura; Tatsu Shimoyama; Yoshiharu Maeda; Fumiyuki Takahashi; Kazuhisa Takahashi; Tomohide Tamura; Fumiaki Koizumi

  Molecular cancer therapeutics, Jun. 2015, Peer-reviewed

  
• High-Density Dielectrophoretic Microwell Array for Detection, Capture, and Single-Cell Analysis of Rare Tumor Cells in Peripheral Blood.

  Atsushi Morimoto; Toshifumi Mogami; Masaru Watanabe; Kazuki Iijima; Yasuyuki Akiyama; Koji Katayama; Toru Futami; Nobuyuki Yamamoto; Takeshi Sawada; Fumiaki Koizumi; Yasuhiro Koh

  PloS one, 2015, Peer-reviewed

  
• A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood.

  Masaru Watanabe; Masakuni Serizawa; Takeshi Sawada; Kazuo Takeda; Toshiaki Takahashi; Nobuyuki Yamamoto; Fumiaki Koizumi; Yasuhiro Koh

  Journal of translational medicine, 23 May 2014, Peer-reviewed

  
• Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.

  Masaru Watanabe; Yuri Uehara; Namiko Yamashita; Yuu Fujimura; Kaori Nishio; Takeshi Sawada; Kazuo Takeda; Fumiaki Koizumi; Yasuhiro Koh

  Cytometry. Part A : the journal of the International Society for Analytical Cytology, Mar. 2014, Peer-reviewed

  
• Long-term complete remission in a patient with intravascular large B-cell lymphoma with central nervous system involvement.

  Takeshi Sawada; Yasushi Omuro; Takeshi Kobayashi; Tunekazu Hishima; Fumiaki Koizumi; Yusuke Kanemasa; Tatsu Shimoyama; Eisaku Sasaki; Yoshiharu Maeda

  OncoTargets and therapy, 2014, Peer-reviewed

  
• MicroRNA expression and outcome in resected NSCLC--letter.

  Shun-ichiro Kageyama; Yusuke Takagi; Takeshi Sawada; Natsuko Kageyama-Yahara; Masahiko Shibuya

  Cancer research, 01 Aug. 2011, Peer-reviewed

  
• Mortality and medical morbidity beyond 2 years after allogeneic hematopoietic stem cell transplantation: experience at a single institution

  W. Munakata; T. Sawada; T. Kobayashi; K. Kakihana; T. Yamashita; K. Ohashi; Y. Onozawa; H. Sakamaki; H. Akiyama

  International Journal of Hematology, Apr. 2011, Peer-reviewed

  
• A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease.

  Chie Onishi; Kazuteru Ohashi; Takeshi Sawada; Mikako Nakano; Takeshi Kobayashi; Takuya Yamashita; Hideki Akiyama; Hisashi Sakamaki

  International journal of hematology, Apr. 2010, Peer-reviewed

  
• Multiple myeloma with multiple and bulky extramedullary plasmacytomas as initial presentation.

  Takeshi SAWADA; Yuho NAJIMA; Kazuteru OHASHI; Ikuma KATO; Maho MIYAZAWA; Mikako NAKANO; Takeshi KOBAYASHI; Takuya YAMASHITA; Hideki AKIYAMA; Hisashi SAKAMAKI

  [Rinsho ketsueki] The Japanese journal of clinical hematology, Nov. 2009, Peer-reviewed

  

Misc.

• ポリADPリボース集積活性を有する抗がん剤候補MO2455の同定と構造活性相関

  松野研司; 橋本知子; 小林寛幸; 大野修; ISLAM Rafiqul; 大川原正; 高村岳樹; 佐々木由香; 佐々木由香; 小野寺貴恵; 小野寺貴恵; 藤森浩彰; 藤森浩彰; 小泉史朗; 下山達; 澤田武志; 秋元茉莉; 石川吉伸; 入江徹美; 井上謙吾; 益谷美都子; 益谷美都子

  メディシナルケミストリーシンポジウム講演要旨集, 2018

  
• 乳癌研究:最近のトピックス【血中がん細胞診断 血中循環腫瘍細胞測定・解析技術の臨床応用への期待】

  小泉史明; 澤田武志

  月刊細胞, 2016

  
• 当科におけるGemcitabine/nab-paclitaxel療法を施行した進行・再発膵癌患者の検討

  田村美宝; 小室泰司; 奥屋俊宏; 船坂知華子; 山口津加彩; 金政佑典; 澤田武志; 下山達; 前田義治

  日本癌治療学会学術集会(Web), 2016

  
• pegfilgrastim承認後のDLBCL患者におけるR-CHOP療法の相対治療強度の変化

  金政佑典; 下山達; 佐々木友希; 山口津加彩; 船坂知華子; 田村美宝; 澤田武志; 小室泰司; 比島恒和; 前田義治

  日本癌治療学会学術集会(Web), 2016

  
• R-CHOP療法施行悪性リンパ腫患者におけるST合剤によるニューモシスチス肺炎予防に関する検討

  石山雄太; 下山達; 佐々木友希; 田村美宝; 澤田武志; 金政佑典; 小室泰司; 前田義治

  日本臨床腫瘍学会学術集会(CD-ROM), 2016

  
• 次世代シーケンサーによる血中循環腫瘍細胞(CTC)の一細胞変異解析

  鈴木智子; 鈴木智子; 澤田武志; 森本篤史; 下山達; 洪泰浩; 田村研治; 田村友秀; 二見達; 岡野栄之; 小泉史明; 小泉史明

  日本人類遺伝学会大会プログラム・抄録集, 2015

  
• A retrospective analysis of second line chemotherapy for HER2-positive advanced gastric cancer

  小室泰司; 野口瑛美; 澤田武志; 工藤昌尚; 下山達; 佐々木栄作; 岡元るみ子; 前田義治; 佐々木常雄

  日本胃癌学会総会記事, 2012

  
• Advanced/Recurrent alpha-fetoprotein producing gastric cancer: Clinical analysis in a single institution

  澤田武志; 佐々木栄作; 工藤昌尚; 下山達; 小室泰司; 岡元るみ子; 前田義治; 佐々木常雄

  日本胃癌学会総会記事, 2012

  
• The efficacy of I-LV/5FU for metastatic gastric cancer resistant to fluoropyrimidines, irinotecan, and taxanes

  野口瑛美; 佐々木栄作; 澤田武志; 工藤昌尚; 下山達; 小室泰司; 岡元るみ子; 前田義治; 佐々木常雄

  日本胃癌学会総会記事, 2012

  
• 当院における急性白血病移植後再発例に対する治療法の後方視的検討

  葉名尻良; 大橋一輝; 澤田武; 森甚一; 菊池拓; 永田安伸; 田岡謙一; 若林志穂子; 小林武; 山下卓也; 秋山秀樹; 坂巻壽

  日本造血細胞移植学会総会プログラム・抄録集, 2010

  
• Prognostic significance of CD30 expression in patients with diffuse large B-cell lymphoma

  Yusuke Kanemasa; Tatsu Shimoyama; Yuki Sasaki; Miho Tamura; Takeshi Sawada; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda

  ANNALS OF ONCOLOGY, Oct. 2017

  
• Outcome Analysis of DLBCL in HIV-infected and non-HIV-infected patients

  Yusuke Kanemasa; Tatsu Shimoyama; Yuki Sasaki; Miho Tamura; Takeshi Sawada; Yasushi Omuro; Ryoko Sekiya; Naoki Yanagisawa; Akifumi Imamura; Tsunekazu Hishima; Yoshiharu Maeda

  ANNALS OF ONCOLOGY, Jul. 2016

  
• Study of Pneumocystis Pneumonia of Trimethoprim/Sulfamethoxazole in NHL patients receiving R-CHOP regimen

  Yuta Ishiyama; Tatsu Shimoyama; Yuki Sasaki; Miho Tamura; Takeshi Sawada; Yusuke Kanemasa; Yasushi Omuro; Yoshiharu Maeda

  ANNALS OF ONCOLOGY, Jul. 2016

  
• Central nervous system relapse in diffuse large B-cell lymphoma: analysis of risk factors and a new prognostic model

  Yusuke Kanemasa; Tatsu Shimoyama; Yuki Sasaki; Sawada Takeshi; Eisaku Sasaki; Yasushi Omuro; Yoshiharu Maeda; Tsunekazu Hishima; Tsuneo Sasaki

  ANNALS OF ONCOLOGY, Nov. 2015

  
• Beta-2 microglobulin as a significant prognostic factor and a new risk model for diffuse large B-Cell lymphoma

  Tsukasa Yamaguchi; Yusuke Kanemasa; Takeshi Sawada; Tatsu Shimoyama; Eisaku Sasaki; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda; Tsuneo Sasaki

  ANNALS OF ONCOLOGY, Nov. 2015

  
• Dielectrophoretic microwell array system for detection circulating tumor cells in patients with solid tumors and single cell analysis of detected circulating tumor cells

  Takeshi Sawada; Atsushi Morimoto; Tatsu Shimoyama; Toshinari Yamashita; Toshifumi Mogami; Kazuki Iijima; Mayu Yunokawa; Shintaro Kanda; Yasuyuki Akiyama; Koji Katayama; Masaru Watanabe; Yasuhiro Koh; Kenji Tamura; Tomohide Tamura; Toru Futami; Fumiaki Koizumi

  CANCER RESEARCH, Aug. 2015

  
• Circulating tumor cells(CTC)―測定技術から分離解析技術への発展―

  SAWADA TAKESHI; KOIZUMI FUMIAKI

  がん分子標的治療, 03 Apr. 2015

  
• EGFR‐TKI耐性肺癌に対するgefitinib・PEM/S‐1併用療法および血漿中変異EGFRモニタリングの前向き試験

  NAKAHARA YOSHIRO; NAKAHARA YOSHIRO; TAKAGI YUSUKE; TAKAGI YUSUKE; HOSOMI YUKIO; KAGEI AKIKO; YAMAMOTO TOMOHIRO; SAWADA TAKESHI; YOMOTA MAKIKO; OKUMA YUSUKE; OKAMURA TATSURU

  日本臨床腫瘍学会学術集会(CD-ROM), 2015

  
• 成熟B細胞リンパ腫における髄液中DNA濃度の検討

  SAWADA TAKESHI; KOIZUMI FUMIAKI; SAITO MAKOTO; KANEMASA YUSUKE; SHIMOYAMA TATSU; SASAKI EISAKU; OMURO YASUSHI; MAEDA YOSHIHARU

  日本臨床腫瘍学会学術集会(CD-ROM), 2015

  
• A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of circulating tumor cells

  Yasuhiro Koh; Masaru Watanabe; Takeshi Sawada; Hirotsugu Kenmotsu; Masakuni Serizawa; Masayuki Ishige; Kazuo Takeda; Nobuyuki Yamamoto; Toshiaki Takahashi; Fumiaki Koizumi

  CANCER RESEARCH, Oct. 2014

  
• Effects of VEGF inhibition on skin ulcer induced by administration of cytotoxic anticancer drugs

  Tatsu Shimoyama; Kiyoshi Ogura; Yuusuke Kanemasa; Shigeo Yamaguti; Eisaku Sasaki; Yasushi Omuro; Takeshi Sawada; Fumiaki Koizumi; Yoshiharu Maeda

  CANCER RESEARCH, Oct. 2014

  
• A preclinical study of a novel FACS-based rare cell capture platform for the detection, capture and molecular characterization of circulating tumor cells.

  Masaru Watanabe; Masakuni Serizawa; Takeshi Sawada; Yuu Fujimura; Fumiaki Koizumi; Yasuhiro Koh

  MOLECULAR CANCER THERAPEUTICS, Nov. 2013

  
• 新型セルソーターと次世代シークエンサーを用いた血中循環腫瘍細胞(CTC)の遺伝子変異解析の基礎検討

  渡辺勝; 芹澤昌邦; 澤田武志; 伊藤由樹子; 藤村祐; 小泉史明; 洪泰浩

  日本肺癌学会総会号, 05 Oct. 2013

  
• Molecular characterization of captured circulating tumor cells with a novel cell sorting system

  Maseru Watanabe; Takeshi Sawada; Masakuni Serizawa; Yukiko Ito; Yuu Fujimura; Fumiaki Koizumi; Yasuhiro Koh

  CANCER RESEARCH, Apr. 2013

  
• 当科における切除不能進行膵癌に対する治療成績

  村田裕人; 小室泰司; 澤田武志; 野口瑛美; 大熊裕介; 工藤昌尚; 下山達; 佐々木栄作; 岡元るみ子; 前田義治; 佐々木常雄

  日本臨床腫瘍学会学術集会プログラム・抄録集, 2012

  
• HER2陽性胃癌に対する化学療法の検討

  小室泰司; 村田裕人; 野口瑛美; 澤田武志; 工藤昌尚; 下山達; 佐々木栄作; 岡元るみ子; 前田義治; 佐々木常雄

  日本臨床腫瘍学会学術集会プログラム・抄録集, 2012

  
• 主なレジメン26の治療・看護スケジュール表つき 消化器がん化学療法看護のポイント 3部 副作用への看護 13 腎機能障害の看護

  澤田武志; 前田義治

  消化器外科Nursing, 05 Oct. 2011

  
• 胃原発絨毛癌の2剖検例

  下井辰徳; 澤田武志; 野口瑛美; 工藤昌尚; 下山達; 佐々木栄作; 小室泰司; 岡元るみ子; 前田義治; 佐々木常雄

  日本癌治療学会誌, 13 Sep. 2011

  
• 中枢神経系転移を有する胃癌患者の単施設における後方視的検討

  澤田武志; 佐々木栄作; 工藤昌尚; 下山達; 小室泰司; 岡元るみ子; 前田義治; 佐々木常雄

  日本癌治療学会誌, 13 Sep. 2011

  
• そこが知りたい!がん化学療法とケアQ&A―臨床現場からの100の質問に答えます―13.その他の副作用と生活上の注意点 Q71 心毒性のある抗がん剤で治療すると聞きました.心機能はどのようなところを観察すれば良いですか?

  澤田武志; 佐々木栄作

  ナーシングケアQ&A, 13 Feb. 2011

  
• そこが知りたい!がん化学療法とケアQ&A―臨床現場からの100の質問に答えます―2.抗がん剤投与方法と経路,注意点 Q17 TS‐1などの内服薬を内服後に嘔吐してしまった際,追加内服するのかしないのかの判断基準はありますか?

  澤田武志; 佐々木栄作

  ナーシングケアQ&A, 13 Feb. 2011

  
• そこが知りたい!がん化学療法とケアQ&A―臨床現場からの100の質問に答えます―2.抗がん剤投与方法と経路,注意点 Q21 ポートの違和感が出現する理由は何が考えられますか?どのくらいの間隔でX線確認をするのですか?

  澤田武志; 佐々木栄作

  ナーシングケアQ&A, 13 Feb. 2011

  
• そこが知りたい!がん化学療法とケアQ&A―臨床現場からの100の質問に答えます―2.抗がん剤投与方法と経路,注意点 Q20 CVポートを使って抗がん剤治療した患者さんには,生理食塩液やヘパリン生食でロックするのは,なぜですか?

  澤田武志; 佐々木栄作

  ナーシングケアQ&A, 13 Feb. 2011

  
• そこが知りたい!がん化学療法とケアQ&A―臨床現場からの100の質問に答えます―2.抗がん剤投与方法と経路,注意点 Q22 ポートから抗がん剤を注入されている時に,シートベルトをしても大丈夫ですか?

  澤田武志; 佐々木栄作

  ナーシングケアQ&A, 13 Feb. 2011

  
• 診断に苦慮したEBV感染による急性肝炎の1例

  久田真弓; 木村公則; 今村潤; 佐伯俊一; 澤田武志; 岡元るみ子; 前田義治; 比島恒和; 林星舟

  日本内科学会関東支部関東地方会, 2011

  
• 小細胞肺癌経過中に虹彩転移と脈絡膜転移をきたした1例

  福井翔一; 高木雄亮; 澤田武志; 下井辰徳; 中原善朗; 大熊裕介; 細見幸生; 井口万里; 岡村樹; 澁谷昌彦; 尾崎憲子; 比島恒和

  肺癌, 20 Dec. 2010

  
• 多数の組織球浸潤が見られ,治療抵抗性であった古典的Hodgkinリンパ腫の1例

  澤田武志; 岡元るみ子; 下山達; 佐々木栄作; 小室泰司; 前田義治; 佐々木常雄

  臨床血液, 30 Sep. 2010

  
• 皮膚筋炎を合併した早期胃癌全身リンパ節転移の一例

  澤田武志; 岡元るみ子; 下山達; 佐々木栄作; 小室泰司; 前田義治; 佐々木常雄

  日本癌治療学会誌, 21 Sep. 2010

  
• 初回化学療法をいつまで続けるか 乳がんに対する術後療法をいつまで続けるか

  澤田武志; 山下年成; 岡元るみ子

  月刊腫瘍内科, 28 May 2010

  
• ランダム皮膚生検にて診断し得た頭部MRI梗塞様所見を有する血管内大細胞型B細胞リンパ腫

  澤田武志; 小林武; 葉名尻良; 菊池拓; 田岡謙一; 若林志穂子; 山下卓也; 大橋一輝; 秋山秀樹; 坂巻壽; 小室泰司; 比島恒和

  臨床血液, 30 Mar. 2010

  
• 当院における同種造血幹細胞移植後長期生存者に見る代謝・内分泌合併症の検討

  澤田武志; 小林武; 森甚一; 葉名尻良; 菊池拓; 田岡謙一; 若林志穂子; 山下卓也; 大橋一輝; 秋山秀樹; 坂巻壽

  日本造血細胞移植学会総会プログラム・抄録集, 2010

  
• 臍帯血移植後早期のリンパ球回復が移植成績に与える影響についての検討

  小林武; 澤田武志; 葉名尻良; 若林志穂子; 菊池拓; 田岡謙一; 山下卓也; 大橋一輝; 秋山秀樹; 坂巻壽

  日本造血細胞移植学会総会プログラム・抄録集, 2010

  
• 胃全摘術後補助療法を経た後に骨格筋転移を来した胃癌の1例

  澤田武志; 前田義治; 下山達; 佐々木栄作; 小室泰司; 岡元るみ子; 佐々木常雄

  日本内科学会関東支部関東地方会, 2010

  
• 同種造血幹細胞移植後の呼吸器合併症について単施設での後方視的検討

  若林志穂子; 大橋一輝; 澤田武志; 森甚一; 葉名尻良; 神谷泉; 菊池拓; 永田安伸; 田岡謙一; 小林武; 山下卓也; 秋山秀樹; 坂巻壽

  日本造血細胞移植学会総会プログラム・抄録集, 2010

  
• AKI分類を用いた造血幹細胞移植後急性腎不全の診断と予後評価

  森甚一; 安藤稔; 澤田武志; 葉名尻良; 菊池拓; 永田安伸; 田岡謙一; 若林志穂子; 小林武; 山下卓也; 大橋一輝; 秋山秀樹; 坂巻壽

  日本造血細胞移植学会総会プログラム・抄録集, 2010

  
• 同種造血幹細胞移植後再発に対する再移植の単施設における後方視的検討

  菊池拓; 山下卓也; 森甚一; 下井辰徳; 澤田武志; 神谷泉; 石垣和慶; 葉名尻良; 永田安伸; 田岡謙一; 若林志穂子; 小林武; 大橋一輝; 秋山秀樹; 坂巻壽

  日本造血細胞移植学会総会プログラム・抄録集, 2010

  
• 当院における造血幹細胞移植後のサイトメガロウイルス感染症に対する治療成績について

  田岡謙一; 山下卓也; 澤田武志; 葉名尻良; 菊池拓; 若林志穂子; 小林武; 大橋一輝; 秋山秀樹; 坂巻壽

  日本造血細胞移植学会総会プログラム・抄録集, 2010

  
• 造血幹細胞移植合併症のコントロールがNK/T細胞リンパ腫の治療成績を向上させる

  澤田武志; 岡元るみ子; 下山達; 佐々木栄作; 小室泰司; 前田義治; 佐々木常雄

  日本臨床腫瘍学会学術集会プログラム・抄録集, 2010

  
• 多発性髄外形質細胞腫で発症した多発性骨髄腫の1例

  小林武; 澤田武志; 大橋一輝; 秋山秀樹

  血液フロンティア, 30 Dec. 2009

  
• 同種造血幹細胞移植後の絶食と急性GVHD発症についての検討

  葉名尻良; 大橋一輝; 澤田武志; 森甚一; 菊池拓; 田岡謙一; 大西千恵; 若林志穂子; 小林武; 山下卓也; 秋山秀樹; 坂巻壽

  臨床血液, 30 Sep. 2009

  
• 非血縁者間骨髄移植後のEBウイルス関連リンパ増殖性疾患にRituximabが奏功した一例

  若林志穂子; 大橋一輝; 角野萌; 森甚一; 葉名尻良; 菊池拓; 田岡謙一; 澤田武志; 大西千恵; 小林武; 山下卓也; 秋山秀樹; 坂巻壽

  臨床血液, 30 Sep. 2009

  
• 臍帯血移植後再発したimatinib抵抗性慢性骨髄性白血病の急性転化に対するdasatinibと化学療法の併用療法

  森甚一; 大橋一輝; 澤田武志; 葉名尻良; 菊池拓; 永田安伸; 大西千恵; 田岡謙一; 若林志穂子; 小林武; 山下卓也; 秋山秀樹; 坂巻壽

  臨床血液, 30 Sep. 2009

  
• 移植後血小板再低下の単施設における後方視的検討

  菊池拓; 山下卓也; 澤田武志; 森甚一; 葉名尻良; 田岡謙一; 大西千恵; 若林志穂子; 小林武; 大橋一輝; 秋山秀樹; 坂巻壽

  臨床血液, 30 Sep. 2009

  
• GVHDに対するMMF(Mycophenolate mofetil)の治療成績:単施設における20例の検討

  澤田武志; 大西千恵; 大橋一輝; 森甚一; 葉名尻良; 菊池拓; 田岡謙一; 若林志穂子; 小林武; 山下卓也; 秋山秀樹; 坂巻壽

  臨床血液, 30 Sep. 2009

  
• 10年以上持続のCRP値およびγグロブリン値著高を呈するIdiopathic Plasmacytic Lymphadenopathyの一例

  澤田武志; 猪熊茂子; 瀧澤泰伸; 鈴木快枝; 丸山順子; 小野田雅仁; 瀬戸口京吾; 根本哲生

  関東リウマチ, 28 Feb. 2009

  
• Multiple myeloma with multiple and bulky extramedullary plasmacytomas initial presentation

  SAWADA TAKESHI; OHASHI KAZUTERU; KATO IKUMA; MIYAZAWA MAHO; NAKANO MIKAKO; KOBAYASHI TAKESHI; YAMASHITA TAKUYA; AKIYAMA HIDEKI; SAKAMAKI HISASHI

  臨床血液, 2009

  
• 巨大な多発性の髄外病変を伴い非典型的な臨床経過をたどった多発性骨髄腫の1例

  澤田武志; 名島悠峰; 永田安伸; 菊池拓; 植木俊充; 小林武; 山本正英; 山下卓也; 大橋一輝; 秋山秀樹; 坂巻壽

  臨床血液, 29 Feb. 2008

  

Presentations

• Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042

  Kaname Nosaki; Hideo Saka; Yukio Hosomi; Paul Baas; Gilberto de; Castro Jr; Martin Reck; Yi-Long Wu; Julie R Brahmer; Enriqueta Felip; Takeshi Sawada; Kazuo Noguchi; Shi Rong Han; Bilal Piperdi; Debra A Kush; Gilberto Lopes

  ESMO selected BEST Abstract plenary session, Apr. 2019

  
• Immune system pathway activation for prediction of the response to neoadjuvant chemotherapy in triple negative breast cancer

  Takeshi Sawada; Riet Hilhorst; Savithri Rangarajan; Masayuki Yoshida; Yuko Tanabe; Kenji Tamura; Takayuki Kinoshita; Rinie van Beuningen; Rob Ruijtenbeek; Hitoshi Tsuda; Fumiaki Koizumi

  American Association for Cancer Research Annual Meeting 2017, Apr. 2017

  
• Mutational analysis of primary tumors and single circulating tumor cells captured by a novel dielectrophoretic microwell array system in metastatic lung cancer, oral cancer and breast cancer patients

  Takeshi Sawada; Atsushi Morimoto; Yasuyuki Akiyama; Tomoko Suzuki; Yukio Hosomi; Yusuke Okuma; Hirotoshi Horio; Masahiko Harada; Sadao Oyama; Chiharu Ogawa; Toshinari Yamashita; Yoshiharu Maeda; Tatsu Shimoyama; Tsunekazu Hishima; Fumiaki Koizumi

  The 28th EORTC-NCI-AACR symposium, Dec. 2016

  
• Developing Circulating Tumor Cell Detection Systems

  The 1st Circulating Tumor Cell Forum 2016, May 2016

  
• Identification of a novel compound, MO2455, that induces poly(ADP-ribose) (PAR) accumulation and inhibits the growth of cancer cells in vitro and in vivo

  Tatsu Shimoyama; Takeshi Sawada; Mari Akimoto; Yuka Sasaki; Hiroaki Fujimori; Yoshinobu Ishikawa; Tadashi Okawara; Tetsumi Irie; Takeji Takamura; Kenji Matsuno; Kengo Inoue; Mitsuko Masutani; Fumiaki Koizumi

  American Association for Cancer Research Annual Meeting 2016, Apr. 2016

  
• Prognostic impact of CTC detected using a novel fluidic cell microarray chip CTC detection system in patients with breast cancer

  Takeshi Sawada; Jungo Araki; Toshinari Yamashita; Manami Masubuchi; Tsuneko Chiyoda; Mayu Yunokawa; Kumiko Hoshi; Shoichi Tao; Shohei Yamamura; Shouki Yatsushiro; Kaori Abe; Masatoshi Kataoka; Tatsu Shimoyama; Yoshiharu Maeda; Katsumasa Kuroi; Kenji Tamura; Tsuneo Sawazumi; Hironobu Minami; Yoshihiko Suda; Fumiaki Koizumi

  American Association for Cancer Research Annual Meeting 2016, Apr. 2016

  
• Circulating tumor cells as a potential sample for proof of concept studies in drug development

  Takeshi Sawada; Masako Takatsu; Tomoko Suzuki; Mari Akimoto; Atsushi Morimoto; Yusuke Kanemasa; Tatsu Shimoyama; Yasushi Omuro; Toshinari Yamashita; Yoshiharu Maeda; Toru Futami; Fumiaki Koizumi

  The 74th Annual Meeting of the Japanese Cancer Association, Oct. 2015

  
• Evaluation of prognostic value of beta-2 microglobulin and a new risk model for DLBCL patients

  Yusuke Kanemasa; Tatsu Shimoyama; Yuki Sasaki; Takeshi Sawada; Eisaku Sasaki; Yasushi Omuro; Tsunekazu Hishima; Yoshiharu Maeda

  The 77th Annual Meeting of the Japanese Society of Hematology, Oct. 2015

  
• DNA fragments concentration in cerebrospinal fluid and CNS relapse risk in mature B-cell lymphoma

  Takeshi Sawada; Fumiaki Koizumi; Makoto Saitoh; Yusuke Kanemasa; Tatsu Shimoyama; Eisaku Sasaki; Yasushi Omuro; Yoshiharu Maeda

  The 77th Annual Meeting of the Japanese Society of Hematology, Oct. 2015

  
• Dielectrophoretic microwell array system for detection circulating tumor cells in patients with solid tumors and single cell analysis of detected circulating tumor cells

  Takeshi Sawada; Atsushi Morimoto; Tatsu Shimoyama; Toshinari Yamashita; Toshifumi Mogami; Kazuki Iijima; Mayu Yunokawa; Shintaro Kanda; Yasuyuki Akiyama; Koji Katayama; Masaru Watanabe; Yasuhiro Koh; Kenji Tamura; Tomohide Tamura; Toru Futami; Fumiaki Koizumi

  American Association for Cancer Research Annual Meeting 2015, Apr. 2015

  
• a novel dielectrophoretic microwell array system for detection and single cell analysis of circulating tumor cells from breast cancer patients

  Takeshi Sawada; Atsushi Morimoto; Masaru Watanabe; Toshifumi Mogami; Kazuki Iijima; Yasuyuki Akiyama; Koji Katayama; Toru Futami; Mayu Yunokawa; Kenji Tamura; Yasuhiro Koh; Fumiaki Koizumi

  The 26th EORTC-NCI-AACR SYMPOSIUM, Nov. 2014

  
• Detection of EGFR mutation in cell free DNA in plasma from lung cancer patients before and after treatment of TKI

  Takeshi Sawada; Tatsu Shimoyama; Yoshiharu Maeda; Shintaro Kanda; Hidehito Horinouchi; Yutaka Fujiwara; Hiroshi Nokihara; Noboru Yamamoto; Tomohide Tamura; Fumiaki Koizumi

  The 73th Annual Meeting of the Japanese Cancer Association, Sep. 2014

  
• Effects of VEGF inhibiton on skin ulcer induced by administration of cytotoxic anticancer drugs

  Tatsu Shimoyama; Kiyoshi Ogura; Yuusuke Kanemasa; Shigeo Yamaguti; Eisaku Sasaki; Yasusi Omuro; Takeshi Sawada; Fumiaki Koizumi; Yoshiharu Maeda

  American Association for Cancer Research Annual Meeting 2013, Apr. 2014

  
• A preclinical study of a novel flow cytometry-based rare cell capture platform for the detection, capture and molecular characterization of circulating tumor cells

  Masaru Watanabe; Masakuni Serizawa; Takeshi Sawada; Yuu Fujimura; Fumiaki Koizumi; Yasuhiro Koh

  AACR-NCI-EORTC International Conference 2013, Nov. 2013

  
• Clinical feasibility study of a novel sorting system for detecting EGFR mutations from captured circulating tumor cells in patients with lung cancer

  Takeshi Sawada; Masaru Watanabe; Yasuhiro Koh; Yuu Fujimura; Hidehito Horinouchi; Shintaro Kanda; Yutaka Fujiwara; Hiroshi Nokihara; Noboru Yamamoto; Tomohide Tamura; Fumiaki Koizumi

  15th World Conference on Lung Cancer, Oct. 2013

  
• Clinical feasibility study of a novel sorting system for detecting PIK3CA mutations from captured circulating tumor cells in patients with breast cancer

  Takeshi Sawada; Kenji Tamura; Yukiko Ito; Masaru Watanabe; Yuu Fujimura; Jun Hashimoto; Mayu Yunokawa; Yasuhiro Koh; Yasuhiro Fujiwara; Fumiaki Koizumi

  The European Cancer Congress 2013, Sep. 2013

  
• Molecular characterization of captured circulating tumor cells (CTCs) with a novel cell sorting system

  Masaru Watanabe; Takeshi Sawada; Masakuni Serizawa; Yukiko Ito; Yuu Fujimura; Fumiaki Koizumi; Yasuhiro Koh

  American Association for Cancer Research Annual Meeting 2013, Apr. 2013

  
• Detection of circulating tumor cells for malignant epithelial tumor using a novel cytometry-based system

  Yukiko Ito; Takeshi Sawada; Masaru Watanabe; Yuu Fujimura; Jun Hashimoto; Makoto Kodaira; Mayu Yunokawa; Harukaze Yamamoto; Kan Yonamori; Chikako Shimizu; Kenji Tamura; Yasuhiro Fujiwara; Yasuhiro Koh; Fumiaki Koizumi

  American Association for Cancer Research Annual Meeting 2013, Apr. 2013

  

Awards

• Apr. 2012

  がん研究振興財団, Awardee of Research Resident Fellowship for the 3rd Term Comprehensive 10-year Strategy for Cancer Control
• Apr. 2014

  日本医療研究開発機構（AMED), Awardee of Research Resident Fellowship
• Nov. 2014

  AACR, the 26th EORTC-NCI-AACR symposium
• Nov. 2016

  AACR, the 28th EORTC-NCI-AACR symposium
• 2017

  MSD株式会社, MSD Japan Clinical Development Award
• 2018

  MSD株式会社, MSD Japan Clinical Development Award
• 2019

  MSD株式会社, MSD Japan Clinical Development Award

External funds: Kakenhi

• ミトコンドリア置換技術を用いた、がん細胞におけるmtDNAの影響の解明

  Grant-in-Aid for Early-Career Scientists

  Basic Section 50010:Tumor biology-related

  Kyoto University

  澤田 武志

  From 01 Apr. 2022, To 31 Mar. 2024, Granted

  ミトコンドリア;Circulating Tumor Cell;ミトコンドリアDNA;CTC;遠隔転移;癌化

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K15526/

External funds: others

• 固形癌に対するGPC-1　CAR-T療法の実用化に向けたex vivo安全性/有効性評価法の確立

  日本医療研究開発機構　, 革新的がん医療実用化研究事業

  From 2021, To 2024

Administration

School management (title, position)

• From 01 Apr. 2021

  外来医長
• From 01 Apr. 2021

  特定講師
• Ki-CONNECTコアミーティング医員